Pathologic thrombopoiesis of rheumatoid arthritis

scientific article

Pathologic thrombopoiesis of rheumatoid arthritis is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1007/S00296-003-0289-0
P698PubMed publication ID12634936

P2093author name stringIsmail Celik
Sedat Kiraz
Meral Calgüneri
Ihsan Ertenli
M Akif Oztürk
Ibrahim c Haznedaroğlu
P2860cites workPlasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosisQ72761104
Establishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis: indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritisQ73069503
Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosisQ73082497
Circulating thrombopoietin in reactive conditions behaves like an acute phase reactantQ73231301
Detection and quantitation of stem cell factor (kit ligand) in the synovial fluid of patients with rheumatic diseaseQ73324331
High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritisQ73345428
The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritisQ73414195
Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective interventionQ73471417
Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteinsQ73828041
Thrombopoietin levels in patients with primary and reactive thrombocytosisQ73892955
Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine networkQ73893252
Induction of c-kit molecules on human CD34+/c-kit < low cells: evidence for CD34+/c-kit < low cells as primitive hematopoietic stem cellsQ73949310
Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?Q74006114
Interleukin-4 inhibits interleukin-11 production by rheumatoid synovial cellsQ74046787
Quantitation of the activity of rheumatoid arthritis. 5. A method for summation of the systemic indices of rheumatoid activityQ74235228
Circulating thrombopoietin in clonal versus reactive thrombocytosisQ74597209
ThrombopoietinQ77218573
Interleukin-1alpha and tumor necrosis factor alpha synergistically stimulate prostaglandin E2-dependent production of interleukin-11 in rheumatoid synovial fibroblastsQ77539476
Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel diseaseQ78148964
Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself withQ78225305
Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosisQ78560054
Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytesQ24305323
Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factorQ24601871
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritisQ24800647
Cytokine signal transductionQ28258951
Hepatic thrombopoietin mRNA is increased in acute inflammationQ28575389
Hematopoietic growth factors: overview and clinical applications, Part I.Q30455192
Characterization of GMP-140 (P-selectin) as a circulating plasma proteinQ30988941
Hematopoietic, immunomodulatory and epithelial effects of interleukin-11.Q33329998
Cytokines, endothelium, and adhesive molecules in pathologic thrombopoiesisQ33336747
Interleukin-11.Q33377512
Murine thrombopoietin mRNA levels are modulated by platelet countQ33488542
The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbitQ33489633
Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridizationQ33498092
Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cellsQ33502872
Thrombopoietin and its receptor: structure, function and role in the regulation of platelet productionQ33546326
Thrombocytosis of active rheumatoid diseaseQ33554737
Human epidermal growth factor for the stratification of synovial lining layer and neovascularisation in rheumatoid arthritisQ33562073
Anti-interleukin 6 receptor antibody treatment in rheumatic diseaseQ34071253
Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibilitQ34113270
Interleukin-11: a new cytokine critical for osteoclast developmentQ34138407
Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritisQ34158420
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitroQ34294815
Expression and secretion of type beta transforming growth factor by activated human macrophagesQ34341606
Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cellsQ34350582
Pluripotent hemopoietic stem cells are c-kitQ34423590
Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte developmentQ34425414
Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cellsQ68822448
Lymphocytes, polymorphonuclear leukocytes, macrophages and platelets in synovium involved by rheumatoid arthritis. A study with monoclonal antibodiesQ68938647
Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapyQ68942078
Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factorQ69083448
Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritisQ69532920
Interleukin-6 is a potent thrombopoietic factor in vivo in miceQ69743063
In vivo platelet survival in rheumatoid arthritisQ70458584
Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cellsQ70988634
Thrombopoietin, megakaryocytopoietic cytokines, and reactive versus clonal megakaryocytopoiesis: an enigma complexQ71017625
Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemiaQ71096713
Effects of desmopressin on circulating P-selectinQ71099056
Platelets in the synovial fluid of patients with rheumatoid arthritisQ71339988
Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosisQ71475041
Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritisQ71641544
Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitroQ71685959
Serotonin content of platelets in inflammatory rheumatic diseases. Correlation with clinical activityQ71701983
Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint diseaseQ71755079
Effects of lnterleukin-1 and Tumor Necrosis Factor on Megakaryocytopoiesis: Mechanism of Reactive ThrombocytosisQ71968982
Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in cultureQ72068985
Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytesQ72370429
Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patientsQ35550183
Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluidsQ35609090
Monocyte-endothelial adhesion in chronic rheumatoid arthritis. In situ detection of selectin and integrin-dependent interactionsQ35610854
Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factorQ35763079
Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localizationQ36018621
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growthQ36351780
Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophilsQ36532906
Investigation of blood platelets in synovial fluid from patients with rheumatoid arthritisQ36642920
Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorptionQ37394770
Platelet-derived growth factor--a growth factor with an expanding role in health and diseaseQ37875458
Transforming growth factor-beta in rheumatoid arthritisQ37886463
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisQ37908865
Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M.Q38316574
The interleukinsQ38696486
Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factorQ39122217
The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.Q40486326
Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosisQ40565765
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosisQ40772902
Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxisQ40904867
Synoviocytes synthesize, bind, and respond to basic fibroblast growth factorQ41199586
Thrombocytosis after major lower extremity trauma: mechanism and possible role in free flap failure.Q41200987
Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF)Q41627045
Stem cell factor induces mast cell adhesion to fibronectin.Q41660106
Elevated serum interleukin-6 levels in patients with reactive thrombocytosisQ41661681
Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritisQ41666122
Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytesQ41967294
Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritidesQ44423590
Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-gammaQ44445115
Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcriptionQ44671490
Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell cultureQ44896680
The role of interleukin 6 and interleukin 1 in megakaryocyte development.Q45940834
Regulation of synovial cell growth. Coexpression of transforming growth factor beta and basic fibroblast growth factor by cultured synovial cellsQ46877620
Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritisQ47685842
P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.Q47957363
Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosisQ47977051
Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.Q50943889
von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.Q51038872
Megakaryocytopoiesis: the state of the art.Q52207242
IL-3 induces differentiation of bone marrow precursor cells to osteoclast-like cells.Q52266894
Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopeniaQ55041393
Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseasesQ57859142
Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factorQ58411945
Connective tissue activation. XII. Platelet abnormalities in patients with rheumatoid arthritisQ67356822
GMP-140 (P-selectin/CD62) binds to chronically stimulated but not resting CD4+ T lymphocytes and regulates their production of proinflammatory cytokinesQ67539003
Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factorQ67675729
Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1Q67697147
Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cellsQ67894798
Characterization of platelet-derived growth factor beta-receptor expressing cells in the vasculature of human rheumatoid synoviumQ67914082
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesQ68094829
Relatonship between interleukin–6 levels and platelet counts in systemic juvenile rheumatoid arthritis: comment on the article by De benedetti et alQ68191450
P433issue2
P921main subjectrheumatoid arthritisQ187255
P304page(s)49-60
P577publication date2003-02-11
P1433published inRheumatology InternationalQ15763689
P1476titlePathologic thrombopoiesis of rheumatoid arthritis
P478volume23

Reverse relations

cites work (P2860)
Q37663613A Study on Association between Common Haematological Parameters and Disease Activity in Rheumatoid Arthritis
Q24303899Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome
Q37182199Changes of Platelet Indices in Juvenile Idiopathic Arthritis in Acute Phase and After Two Months Treatment
Q43213477Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia
Q33548150Differing effect of systemic anti psoriasis therapies on platelet physiology--a case report and review of literature
Q37333790Early growth response-1 (EGR-1) and nuclear factor of activated T cells (NFAT) cooperate to mediate CD40L expression in megakaryocytes and platelets
Q35867724Levels of thrombopoietin in aqueous humor of patients with noninfectious acute anterior uveitis
Q50246344Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds
Q37730557Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.
Q46785420Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis
Q33378654Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis.
Q84969422The relationship between mean platelet volume levels and the inflammation in Helicobacter pylori gastritis
Q38190956Thrombocytosis as a prognostic marker in gastrointestinal cancers
Q83226605Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia
Q35433259Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies

Search more.